glp-1 cancer risk A new Penn Medicine study of more than 110,000 women found that those who took medications were about 30% less likely to develop breast than those who did not. Presented OR | Early GLP-1 Agonist

[5] The scientists reveal that Through activation of GHS-R1a, secretagogues produced a positive inotropic effect on ischemic cardiomyocytes and protected them from I/R injury probably by protecting or recovering p-PLB (and therefore SR Ca2+ content) to allow the maintenance or recovery of normal cardiac contractility. Modified GRF 1-29 & Ipamorelin and Bone Research in growth hormone stimulating peptides such as Modified GRF 1-29 and Ipamorelin suggests that these peptides, particularly Ipamorelin, when observed in murine models, may potentially completely halt bone loss associated with exogenous factors, such as anabolic steroids

doi: 10.1089/aid.1996.12.1537 52 PoggialiE.BastoniD.IoannilliE.VercelliA.MagnacavalloA

Within 8 weeks, energy improved, nausea resolved, and DEXA confirmed preservation of lean mass

But how fast does it really work